Jakstar Pharma

01/12/2025

30/11/2025

29/11/2025

SURGEON WORKING AS MEDICAL SPECIALIST

In many parts of India, it has become increasingly common for medical specialists particularly surgeons and super specialists to extend their outpatient practice beyond the scope of their trained expertise and offer consultations for a wide range of general medical conditions. This trend is observed in both urban and semi-urban healthcare settings and is often driven by patient expectations, workforce shortages, or institutional convenience.

While specialists are qualified medical practitioners, the practice of routinely managing chronic medical conditions such as hypertension, diabetes, rheumatologic disorders, hepatology-related illnesses, and other complex internal medicine concerns falls outside the purview of their formal specialist training. Such practices may inadvertently compromise the quality of care patients receive and may blur established professional boundaries within the healthcare system.

Given the potential implications for patient safety, ethical medical practice, and the appropriate utilization of specialist skills, this issue merits careful attention. Local health authorities, regulatory bodies, and institutional administrators should recognize this growing pattern and consider appropriate guidelines, monitoring mechanisms, and awareness initiatives to ensure that patients receive care from the most appropriately trained specialists.
Regards,
JAKSTAR PHARMA

27/11/2025

The Painkiller That Raises Heart Attack Risk by 50%, Diclofenac's Hidden Danger.
Diclofenac, commonly used for headaches, periods, fever, and body pain, increases cardiac arrest risk by 50% within just 30 days, according to major studies. It raises blood pressure, reduces heart blood flow, triggers clots, and damages stomach and kidneys especially risky for those with high BP, diabetes, kidney issues, acidity, over 40, or frequent users.
Regards,
JAKSTAR PHARMA

27/11/2025

VITAMIN 12 and FEELING COLD :
Feeling cold can be linked to vitamin B12 deficiency because B12 is crucial for producing healthy red blood cells that carry oxygen throughout the body. Inadequate B12 can lead to anemia, specifically vitamin B12 deficiency anemia, which results in poor oxygen circulation and symptoms such as feeling cold, especially in extremities like hands and feet. This cold sensitivity occurs because the body struggles to maintain proper thermoregulation when oxygen delivery to tissues is impaired.
Vitamin B12 deficiency affects the body’s ability to form red blood cells, which reduces oxygen transport and causes symptoms like coldness, fatigue, and weakness. Such deficiency may also make a person more vulnerable to feeling cold even in otherwise normal temperatures. This condition is often diagnosed through blood tests, and treatment can include dietary changes or supplements to restore normal B12 levels and improve thermoregulation.
Other nutrient deficiencies that can contribute to cold sensitivity include iron, folate (vitamin B9), and vitamin C, which collectively support red blood cell formation and oxygen transport. If you frequently feel cold without an obvious environmental cause, checking vitamin B12 and related nutrient levels with a healthcare provider is recommended to address possible deficiencies and avoid complications like anemia.
Regards,
JAKSTAR PHARMA

27/11/2025

GST REDUCTION IN PHARMCEUTICALS AND ITS IMPACT ON ALL STAKEHOLDERS INCLUDING PATIENTS

The recent GST reduction on medicines in India, effective September 2025, has brought significant benefits to all stakeholders in the pharmaceutical supply chain and most importantly, to patients. The GST on 33 critical lifesaving drugs, including those used for cancer and rare diseases, has been completely exempted (NIL GST). Additionally, the GST rate on all other drugs and medicines has been reduced from 12% to 5%. This reform also extends to medical devices and equipment, decreasing their GST from 18% or 12% to 5%. These changes substantially lower the cost burden on patients and improve access to essential healthcare treatments.
For manufacturers, the GST reduction means a simplified tax structure and a more competitive pricing environment, which encourages increased production and innovation. Manufacturers have been mandated to revise the maximum retail prices (MRP) of medicines to reflect the new GST rates, which also helps in making medicines more affordable in the market without the need for re-labeling existing stock. Distributors and retailers benefit from increased sales volumes due to the enhanced affordability of medicines, which ensures a steady supply chain and wider distribution across regions.
End consumers, especially patients suffering from serious and chronic conditions, gain the most from these reforms as the price reductions lead to lower out-of-pocket healthcare expenses. The reduction in GST on medical apparatus and devices also indirectly benefits patients by lowering hospital and diagnostic costs. Overall, the GST cut fosters equitable healthcare access, strengthens public health, and supports the growth and sustainability of the Indian pharmaceutical sector, reinforcing India’s position as a global pharmaceutical hub.

The details of changes are :

• GST on 33 lifesaving drugs is now NIL; on other medicines, reduced from 12% to 5%.
• Medical devices and equipment GST reduced to 5%, lowering healthcare costs.
• Manufacturers revise MRPs downwards, promoting affordability without relabeling burden.
• Distributors and retailers see increased turnover due to greater medicine affordability.
• Patients benefit from reduced treatment costs and better access to essential medications.
This all-around benefit from manufacturers to the end users marks a significant step toward affordable and accessible healthcare in India, contributing positively to public health and the pharma industry alike.
Regards,
JAKSTAR PHARMA